Effect of diabetes on the fracture resistance of bone

Clinical Reviews in Bone and Mineral Metabolism

Volumn 11, Issue 1, 2013, Pages 38-48

  Nyman, Jeffry S ^a,b,c,d  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b Medical Center East   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

Architecture; Biomechanics; Bone quality; Brittleness; Collagen crosslinks; Computed tomography; Hyperglycemia; Strength; Structure; Toughness

Indexed keywords

ADVANCED GLYCATION END PRODUCT; INSULIN;

ALLOXAN DIABETES MELLITUS; ARTICLE; BIOMECHANICS; BONE MASS; BONE MINERALIZATION; BONE STRENGTH; BONE STRUCTURE; BONE TISSUE; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; FRACTURE; FRACTURE RESISTANCE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MUSCULOSKELETAL SYSTEM PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBSERVATION; STREPTOZOCIN DIABETES;

EID: 84874599598     PISSN: 15348644     EISSN: 15590119     Source Type: Journal    
DOI: 10.1007/s12018-012-9124-z     Document Type: Article

References (122)

1. Nicodemus KK, Folsom AR. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care. 2001;24(7):1192-7. (Pubitemid 33716397)
2. Bonds DE, Larson JC, Schwartz AV, Strotmeyer ES, Robbins J, Rodriguez BL, et al. Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study. J Clin Endocrinol Metab. 2006;91(9):3404-10. (Pubitemid 44402111)
3. Schwartz AV, Sellmeyer DE. Diabetes, fracture, and bone fragility. Curr Osteoporos Rep. 2007;5(3):105-11. (Pubitemid 47571960)
4. Janghorbani M, Van Dam RM, Willett WC, Hu FB. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol. 2007;166(5):495-505. (Pubitemid 47283633)
5. Vestergaard P, Rejnmark L, Mosekilde L. Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcif Tissue Int. 2009;84(1):45-55.
6. Lewiecki EM. Management of osteoporosis. Clin Mol Allergy. 2004;2(1):9. (Pubitemid 39111879)
7. Atik OS, Gunal I, Korkusuz F. Burden of osteoporosis. Clin Orthop Relat Res. 2006;443:19-24. (Pubitemid 44324928)
8. Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int. 1997;7(5):407-13. (Pubitemid 27443065)
9. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53. (Pubitemid 38579764)
10. Thrailkill KM, Liu L, Wahl EC, Bunn RC, Perrien DS, Cockrell GE, et al. Bone formation is impaired in a model of type 1 diabetes. Diabetes. 2005;54(10):2875-81. (Pubitemid 41401082)
11. Lapcevic WA, French DD, Campbell RR. All-cause mortality rates of hip fractures treated in the VHA: do they differ from medicare facilities? J Am Med Dir Assoc. 2010;11(2):116-9.
12. Bass E, French DD, Bradham DD, Rubenstein LZ. Risk-adjusted mortality rates of elderly veterans with hip fractures. Ann Epidemiol. 2007;17(7):514-9. (Pubitemid 46950928)
13. Tuominen JT, Impivaara O, Puukka P, Ronnemaa T. Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care. 1999;22(7):1196-200. (Pubitemid 29293977)
14. Danielson KK, Elliott ME, LeCaire T, Binkley N, Palta M. Poor glycemic control is associated with low BMD detected in premenopausal women with type 1 diabetes. Osteoporos Int. 2009;20(6):923-33.
15. Boehm HF, Eckstein F, Wunderer C, Kuhn V, Lochmueller EM, Schreiber K, et al. Improved performance of hip DXA using a novel region of interest in the upper part of the femoral neck: in vitro study using bone strength as a standard of reference. J Clin Densitom. 2005;8(4):488-94. (Pubitemid 41690413)
16. Muller ME, Webber CE, Bouxsein ML. Predicting the failure load of the distal radius. Osteoporos Int. 2003;14(4):345-52. (Pubitemid 40824252)
17. Carter DR, Bouxsein ML, Marcus R. New approaches for interpreting projected bone densitometry data. J Bone Miner Res. 1992;7(2):137-45.
18. Buysschaert M, Cauwe F, Jamart J, Brichant C, De Coster P, Magnan A, et al. Proximal femur density in type 1 and 2 diabetic patients. Diabete Metab. 1992;18(1):32-7.
19. Hampson G, Evans C, Petitt RJ, Evans WD, Woodhead SJ, Peters JR, et al. Bone mineral density, collagen type 1 alpha 1 genotypes and bone turnover in premenopausal women with diabetes mellitus. Diabetologia. 1998;41(11):1314-20. (Pubitemid 28488759)
20. Schwartz AV. Diabetes mellitus: Does it affect bone? Calcif Tissue Int. 2003;73(6):515-9. (Pubitemid 37517795)
21. de L II, van der Klift M, de Laet CE, van Daele PL, Hofman A, Pols HA. Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int. 2005;16(12):1713-20. (Pubitemid 41790880)
22. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos Int. 2007;18(4):427-44. (Pubitemid 46354916)
23. Wallace C, Reiber GE, LeMaster J, Smith DG, Sullivan K, Hayes S, et al. Incidence of falls, risk factors for falls, and fall-related fractures in individuals with diabetes and a prior foot ulcer. Diabetes Care. 2002;25(11):1983-6. (Pubitemid 41071055)
24. Schwartz AV, Hillier TA, Sellmeyer DE, Resnick HE, Gregg E, Ensrud KE, et al. Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care. 2002;25(10):1749-54. (Pubitemid 41071081)
25. Forsen L, Meyer HE, Midthjell K, Edna TH. Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trondelag Health Survey. Diabetologia. 1999;42(8):920-5. (Pubitemid 29369598)
26. Schwartz AV, Sellmeyer DE, Ensrud KE, Cauley JA, Tabor HK, Schreiner PJ, et al. Older women with diabetes have an increased risk of fracture: a Prospective Study. J Clin Endocrinol Metab. 2001;86(1):32-8. (Pubitemid 32109771)
27. Ottenbacher KJ, Ostir GV, Peek MK, Goodwin JS, Markides KS. Diabetes mellitus as a risk factor for hip fracture in Mexican American older adults. J Gerontol A Biol Sci Med Sci. 2002;57(10):M648-53.
28. De Laet CE, Van Hout BA, Burger H, Weel AE, Hofman A, Pols HA. Hip fracture prediction in elderly men and women: validation in the Rotterdam study. J Bone Miner Res. 1998;13(10):1587-93. (Pubitemid 28465299)
29. Kanis JA, Johnell O, Oden A, Dawson A, De Laet C, Jonsson B. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int. 2001;12(12):989-95. (Pubitemid 34105967)
30. Pressman AR, Lo JC, Chandra M, Ettinger B. Methods for assessing fracture risk prediction models: experience with FRAX in a large integrated health care delivery system. J Clin Densitom. 2011;14(4):407-15. doi: 10.1016/j.jocd.2011. 06.006.
31. Schwartz AV, Vittinghoff E, Bauer DC, Hillier TA, Strotmeyer ES, Ensrud KE, et al. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. Jama. 2011;305(21):2184-92. doi: 10.1001/jama.2011.715.
32. Giangregorio L, Leslie W, Lix L, Johansson H, Oden A, McCloskey E, et al. FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res. 2011;. doi: 10.1002/jbmr.556.
33. Rho JY, Kuhn-Spearing L, Zioupos P. Mechanical properties and the hierarchical structure of bone. Med Eng Phys. 1998;20(2):92-102. (Pubitemid 28318322)
34. Gupta HS, Zioupos P. Fracture of bone tissue: the 'hows' and the 'whys'. Med Eng Phys. 2008;30(10):1209-26.
35. Ritchie RO. How does human bone resist fracture? Ann N Y Acad Sci. 2010;1192:72-80. doi: 10.1111/j.1749-6632.2009.05232.x.
36. Turner CH, Burr DB. Basic biomechanical measurements of bone: a tutorial. Bone. 1993;14(4):595-608. (Pubitemid 23198821)
37. Martin RB. Determinants of the mechanical properties of bones. J Biomech. 1991;24(Suppl 1):79-88.
38. Teo JC, Si-Hoe KM, Keh JE, Teoh SH. Relationship between CT intensity, micro-architecture and mechanical properties of porcine vertebral cancellous bone. Clin Biomech (Bristol, Avon). 2006;21(3):235-44. doi: 10.1016/j. clinbiomech.2005.11.001. (Pubitemid 43163119)
39. Zysset PK. A review of morphology-elasticity relationships in human trabecular bone: theories and experiments. J Biomech. 2003;36(10):1469-85. (Pubitemid 37117354)
40. Garrison JG, Slaboch CL, Niebur GL. Density and architecture have greater effects on the toughness of trabecular bone than damage. Bone. 2009;44(5):924-9. doi: 10.1016/j.bone.2008.12.030.
41. Shi X, Liu XS, Wang X, Guo XE, Niebur GL. Type and orientation of yielded trabeculae during overloading of trabecular bone along orthogonal directions. J Biomech. 2010;43(13):2460-6. doi: 10.1016/j.jbiomech.2010.05.032.
42. Boivin GY, Chavassieux PM, Santora AC, Yates J, Meunier PJ. Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone. 2000;27(5):687-94.
43. Yerramshetty JS, Akkus O. The associations between mineral crystallinity and the mechanical properties of human cortical bone. Bone. 2008;42(3):476-82.
44. Martin RB, Lau ST, Mathews PV, Gibson VA, Stover SM. Collagen fiber organization is related to mechanical properties and remodeling in equine bone. A comparison of two methods. J Biomech. 1996;29(12):1515-21. (Pubitemid 26381862)
45. Oxlund H, Barckman M, Ortoft G, Andreassen TT. Reduced concentrations of collagen cross-links are associated with reduced strength of bone. Bone. 1995;17(4 Suppl):365S-71S.
46. Muir P, Johnson KA, Ruaux-Mason CP. In vivo matrix microdamage in a naturally occurring canine fatigue fracture. Bone. 1999;25(5):571-6. (Pubitemid 29469463)
47. Kaeding CC, Najarian RG. Stress fractures: classification and management. Phys Sportsmed. 2010;38(3):45-54. doi: 10.3810/psm.2010.10.1807.
48. Jones BH, Harris JM, Vinh TN, Rubin C. Exercise-induced stress fractures and stress reactions of bone: epidemiology, etiology, and classification. Exerc Sport Sci Rev. 1989;17:379-422.
49. Chantelau E, Richter A, Schmidt-Grigoriadis P, Scherbaum WA. The diabetic Charcot foot: MRI discloses bone stress injury as trigger mechanism of neuroarthropathy. Exp Clin Endocrinol Diabetes. 2006;114(3):118-23.
50. Mori S, Burr DB. Increased intracortical remodeling following fatigue damage. Bone. 1993;14(2):103-9. (Pubitemid 23098956)
51. Burr DB, Martin RB, Schaffler MB, Radin EL. Bone remodeling in response to in vivo fatigue microdamage. J Biomech. 1985;18:189-200. (Pubitemid 15112335)
52. Schaffler MB, Choi K, Milgrom C. Aging and matrix microdamage accumulation in human compact bone. Bone. 1995;17(6):521-5. (Pubitemid 26017572)
53. Norman TL, Wang Z. Microdamage of human cortical bone: incidence and morphology in long bones. Bone. 1997;20(4):375-9. (Pubitemid 27196661)
54. Zioupos P. Accumulation of in vivo fatigue microdamage and its relation to biomechanical properties in ageing human cortical bone. J Microsc. 2001;201(Pt 2):270-8. (Pubitemid 32202603)
55. Zioupos P. Accumulation of in vivo fatigue microdamage and its relation to biomechanical properties in ageing human cortical bone. J Microsc. 2001;201(2):270-8. (Pubitemid 32202603)
56. Yeni YN, Brown CU, Wang Z, Norman TL. The influence of bone morphology on fracture toughness of the human femur and tibia. Bone. 1997;21(5):453-9. (Pubitemid 27485315)
57. Yeni YN, Brown CU, Norman TL. Influence of bone composition and apparent density on fracture toughness of the human femur and tibia. Bone. 1998;22(1):79-84. (Pubitemid 28033657)
58. Zioupos P, Currey JD, Hamer AJ. The role of collagen in the declining mechanical properties of aging human cortical bone. J Biomed Mater Res. 1999;45(2):108-16. (Pubitemid 29114158)
59. Wang XD, Masilamani NS, Mabrey JD, Alder ME, Agrawal CM. Changes in the fracture toughness of bone may not be reflected in its mineral density, porosity, and tensile properties. Bone. 1998;23(1):67-72. (Pubitemid 28327503)
60. Issa C, Zantout MS, Azar ST. Osteoporosis in men with diabetes mellitus. J Osteoporos. 2011;2011:651867. doi: 10.4061/2011/651867.
61. Wongdee K, Charoenphandhu N. Osteoporosis in diabetes mellitus: possible cellular and molecular mechanisms. World J Diabetes. 2011;2(3):41-8. doi: 10.4239/wjd.v2.i3.41.
62. Burstein AH, Reilly DT, Martens M. Aging of bone tissue: mechanical properties. J Bone Joint Surg Am. 1976;58(1):82-6.
63. McCalden RW, McGeough JA, Barker MB, Court-Brown CM. Age-related changes in the tensile properties of cortical bone. The relative importance of changes in porosity, mineralization, and microstructure. J Bone Joint Surg Am. 1993;75(8):1193-205. (Pubitemid 23267911)
64. Zioupos P, Currey JD, Hamer AJ. The role of collagen in the declining mechanical properties of aging human cortical bone. J Biomed Mater Res. 1999;45(2):108-16. (Pubitemid 29114158)
65. Nyman JS, Roy A, Tyler JH, Acuna RL, Gayle HJ, Wang X. Age-related factors affecting the postyield energy dissipation of human cortical bone. J Orthop Res. 2007;25(5):646-55. (Pubitemid 46730517)
66. Zioupos P, Currey JD. Changes in the stiffness, strength, and toughness of human cortical bone with age. Bone. 1998;22(1):57-66. (Pubitemid 28033654)
67. Nalla RK, Kruzic JJ, Kinney JH, Ritchie RO. Effect of aging on the toughness of human cortical bone: evaluation by R-curves. Bone. 2004;35(6):1240-6. (Pubitemid 40260389)
68. Koester KJ, Barth HD, Ritchie RO. Effect of aging on the transverse toughness of human cortical bone: evaluation by R-curves. J Mech Behav Biomed Mater. 2011;4(7):1504-13. doi: 10.1016/j.jmbbm.2011.05.020.
69. Zioupos P, Wang XT, Currey JD. The accumulation of fatigue microdamage in human cortical bone of two different ages in vitro. Clin Biomech (Bristol, Avon). 1996;11(7):365-75. (Pubitemid 26372113)
70. Diab T, Sit S, Kim D, Rho J, Vashishth D. Age-dependent fatigue behaviour of human cortical bone. Eur J Morphol. 2005;42(1-2):53-9. (Pubitemid 41074378)
71. Zioupos P, Gresle M, Winwood K. Fatigue strength of human cortical bone: Age, physical, and material heterogeneity effects. J Biomed Mater Res A. 2007;86(3):627-36.
72. Kruzic JJ, Ritchie RO. Fatigue of mineralized tissues: cortical bone and dentin. J Mech Behav Biomed Mater. 2008;1(1):3-17. (Pubitemid 47557527)
73. Carter DR, Hayes WC, Schurman DJ. Fatigue life of compact bone-II. Effects of microstructure and density. J Biomech. 1976;9(4):211-8.
74. Fleischli JG, Laughlin TJ, Athanasiou K, Lanctot DR, Lavery L, Wang X, et al. Effect of diabetes mellitus on the material properties of the distal tibia. J Am Podiatr Med Assoc. 2006;96(2):91-5. (Pubitemid 43533344)
75. Fleischli JG, Laughlin TJ, Lavery LA, Shah B, Lanctot D, Agrawal CM, et al. The effects of diabetes mellitus on the material properties of human metatarsal bones. J Foot Ankle Surg. 1998;37(3):195-8. (Pubitemid 28280695)
76. Saha MT, Sievanen H, Salo MK, Tulokas S, Saha HH. Bone mass and structure in adolescents with type 1 diabetes compared to healthy peers. Osteoporos Int. 2009;20(8):1401-6.
77. Bechtold S, Putzker S, Bonfig W, Fuchs O, Dirlenbach I, Schwarz HP. Bone size normalizes with age in children and adolescents with type 1 diabetes. Diabetes Care. 2007;30(8):2046-50. (Pubitemid 47219418)
78. Melton LJ 3rd, Riggs BL, Leibson CL, Achenbach SJ, Camp JJ, Bouxsein ML, et al. A bone structural basis for fracture risk in diabetes. J Clin Endocrinol Metab. 2008;93(12):4804-9.
79. Petit MA, Paudel ML, Taylor BC, Hughes JM, Strotmeyer ES, Schwartz AV et al. Bone mass and strength in older men with type 2 diabetes: The Osteoporotic Fractures in Men Study. J Bone Miner Res. 2010;25(2):285-91.
80. Register TC, Lenchik L, Hsu FC, Lohman KK, Freedman BI, Bowden DW, et al. Type 2 diabetes is not independently associated with spinal trabecular volumetric bone mineral density measured by QCT in the Diabetes Heart Study. Bone. 2006;39(3):628-33. doi: 10.1016/j.bone.2006.03.003. (Pubitemid 44149275)
81. Shu A, Yin MT, Stein E, Cremers S, Dworakowski E, Ives R, et al. Bone structure and turnover in type 2 diabetes mellitus. Osteoporos Int. 2011;. doi: 10.1007/s00198-011-1595-0.
82. Burghardt AJ, Issever AS, Schwartz AV, Davis KA, Masharani U, Majumdar S, et al. High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2010;95(11):5045-55. doi: 10.1210/jc.2010-0226.
83. Sell DR, Monnier VM. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J Biol Chem. 1989;264(36):21597-602. (Pubitemid 20028722)
84. Zieman S, Kass D. Advanced glycation end product cross-linking: pathophysiologic role and therapeutic target in cardiovascular disease. Congest Heart Fail. 2004;10(3):144-9. quiz 50-1.
85. Wang X, Shen X, Li X, Agrawal CM. Age-related changes in the collagen network and toughness of bone. Bone. 2002;31(1):1-7. (Pubitemid 34754417)
86. Tomasek JJ, Meyers SW, Basinger JB, Green DT, Shew RL. Diabetic and age-related enhancement of collagen-linked fluorescence in cortical bones of rats. Life Sci. 1994;55(11):855-61. (Pubitemid 24261618)
87. Tang SY, Zeenath U, Vashishth D. Effects of non-enzymatic glycation on cancellous bone fragility. Bone. 2007;40(4):1144-51. (Pubitemid 46386561)
88. Monnier VM, Mustata GT, Biemel KL, Reihl O, Lederer MO, Zhenyu D, et al. Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on "a puzzle nearing resolution". Ann N Y Acad Sci. 2005;1043:533-44. (Pubitemid 41123943)
89. Saito M, Marumo K. Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int. 2010;21(2):195-214.
90. Shiraki M, Kuroda T, Tanaka S, Saito M, Fukunaga M, Nakamura T. Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures. J Bone Miner Metab. 2008;26(1):93-100. (Pubitemid 350307997)
91. Gineyts E, Munoz F, Bertholon C, Sornay-Rendu E, Chapurlat R. Urinary levels of pentosidine and the risk of fracture in postmenopausal women: the OFELY study. Osteoporos Int. 2010;21(2):243-50.
92. Schwartz AV, Garnero P, Hillier TA, Sellmeyer DE, Strotmeyer ES, Feingold KR, et al. Pentosidine and increased fracture risk in older adults with type 2 diabetes. J Clin Endocrinol Metab. 2009;94(7):2380-6.
93. Yamamoto M, Yamaguchi T, Yamauchi M, Yano S, Sugimoto T. Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab. 2008;93(3):1013-9. (Pubitemid 351398587)
94. Saito M, Fujii K, Soshi S, Tanaka T. Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture. Osteoporos Int. 2006;17(7):986-95. (Pubitemid 43864852)
95. Nyman JS, Ni Q, Nicolella DP, Wang X. Measurements of mobile and bound water by nuclear magnetic resonance correlate with mechanical properties of bone. Bone. 2008;42(1):193-9. (Pubitemid 350297186)
96. Vashishth D, Gibson GJ, Khoury JI, Schaffler MB, Kimura J, Fyhrie DP. Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone. 2001;28(2):195-201. (Pubitemid 32140975)
97. Viguet-Carrin S, Farlay D, Bala Y, Munoz F, Bouxsein ML, Delmas PD. An in vitro model to test the contribution of advanced glycation end products to bone biomechanical properties. Bone. 2008;42(1):139-49. (Pubitemid 350302015)
98. Reddy GK. Glucose-mediated in vitro glycation modulates biomechanical integrity of the soft tissues but not hard tissues. J Orthop Res. 2003;21(4):738-43. (Pubitemid 36758219)
99. Gupta HS, Seto J, Wagermaier W, Zaslansky P, Boesecke P, Fratzl P. Cooperative deformation of mineral and collagen in bone at the nanoscale. Proc Natl Acad Sci USA. 2006;103(47):17741-6. (Pubitemid 44852230)
100. Dong XN, Almer JD, Wang X. Post-yield nanomechanics of human cortical bone in compression using synchrotron X-ray scattering techniques. J Biomech. 2011;44(4):676-82. doi: 10.1016/j.jbiomech.2010.11.003.
101. Zimmermann EA, Schaible E, Bale H, Barth HD, Tang SY, Reichert P, et al. Age-related changes in the plasticity and toughness of human cortical bone at multiple length scales. Proc Natl Acad Sci USA. 2011;108(35):14416-21. doi: 10.1073/pnas.1107966108.
102. Chan KS, Chan CK, Nicolella DP. Relating crack-tip deformation to mineralization and fracture resistance in human femur cortical bone. Bone. 2009;45(3):427-34. doi: 10.1016/j.bone.2009.01.468.
103. Hernberg CA. The bone structure in alloxan-induced diabetes mellitus in rats. Acta Med Scand. 1952;142(4):274-83.
104. Nyman JS, Even JL, Jo CH, Herbert EG, Murry MR, Cockrell GE, et al. Increasing duration of type 1 diabetes perturbs the strength-structure relationship and increases brittleness of bone. Bone. 2011;48(4):733-40. doi: 10.1016/j.bone.2010.12.016.
105. Dixit PK, Ekstrom RA. Decreased breaking strength of diabetic rat bone and its improvement by insulin treatment. Calcif Tissue Int. 1980;32(3):195-9. (Pubitemid 11192514)
106. Einhorn TA, Boskey AL, Gundberg CM, Vigorita VJ, Devlin VJ, Beyer MM. The mineral and mechanical properties of bone in chronic experimental diabetes. J Orthop Res. 1988;6(3):317-23.
107. Reddy GK, Stehno-Bittel L, Hamade S, Enwemeka CS. The biomechanical integrity of bone in experimental diabetes. Diabetes Res Clin Pract. 2001;54(1):1-8. (Pubitemid 32782639)
108. Zhang SQ, Chen GH, Lu WL, Zhang Q. Effects on the bones of vanadyl acetylacetonate by oral administration: a comparison study in diabetic rats. J Bone Miner Metab. 2007;25(5):293-301. (Pubitemid 47283264)
109. Silva MJ, Brodt MD, Lynch MA, McKenzie JA, Tanouye KM, Nyman JS, et al. Type 1 diabetes in young rats leads to progressive trabecular bone loss, cessation of cortical bone growth, and diminished whole bone strength and fatigue life. J Bone Miner Res. 2009;24(9):1618-27.
110. Silva MJ, Brodt MD, Lynch MA, McKenzie JA, Tanouye KM, Nyman JS, et al. Type 1 diabetes in young rats leads to progressive trabecular bone loss, cessation of cortical bone growth, and diminished whole bone strength and fatigue life. J Bone Miner Res. 2009;24(9):1618-27. doi: 10.1359/jbmr.090316.
111. Facchini DM, Yuen VG, Battell ML, McNeill JH, Grynpas MD. The effects of vanadium treatment on bone in diabetic and non-diabetic rats. Bone. 2006;38(3):368-77. (Pubitemid 43255431)
112. Prisby RD, Swift JM, Bloomfield SA, Hogan HA, Delp MD. Altered bone mass, geometry and mechanical properties during the development and progression of type 2 diabetes in the Zucker diabetic fatty rat. J Endocrinol. 2008;199(3):379-88.
113. Reinwald S, Peterson RG, Allen MR, Burr DB. Skeletal changes associated with the onset of type 2 diabetes in the ZDF and ZDSD rodent models. Am J Physiol Endocrinol Metab. 2009;296(4):E765-74.
114. Ahmad T, Ohlsson C, Saaf M, Ostenson CG, Kreicbergs A. Skeletal changes in type-2 diabetic Goto-Kakizaki rats. J Endocrinol. 2003;178(1):111-6. (Pubitemid 36927015)
115. Saito M, Fujii K, Mori Y, Marumo K. Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats. Osteoporos Int. 2006;17(10):1514-23. (Pubitemid 44387486)
116. Vestergaard P, Rejnmark L, Mosekilde L. Are antiresorptive drugs effective against fractures in patients with diabetes? Calcif Tissue Int. 2011;88(3):209-14. doi: 10.1007/s00223-010-9450-4.
117. Jude EB, Selby PL, Burgess J, Lilleystone P, Mawer EB, Page SR, et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia. 2001;44(11):2032-7. (Pubitemid 33124049)
118. Selby PL, Young MJ, Boulton AJ. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med. 1994;11(1):28-31. (Pubitemid 24040538)
119. Pakarinen TK, Laine HJ, Maenpaa H, Mattila P, Lahtela J. The effect of zoledronic acid on the clinical resolution of Charcot neuroarthropathy: a pilot randomized controlled trial. Diabetes Care. 2011;34(7):1514-6. doi: 10.2337/dc11-0396.
120. Game FL, Catlow R, Jones GR, Edmonds ME, Jude EB, Rayman G, et al. Audit of acute Charcot's disease in the UK: the CDUK Study. Diabetologia. 2011;. doi: 10.1007/s00125-011-2354-7.
121. Zhang L, Liu Y, Wang D, Zhao X, Qiu Z, Ji H, et al. Bone biomechanical and histomorphometrical investment in type 2 diabetic Goto-Kakizaki rats. Acta Diabetol. 2009;46(2):119-26.
122. Kawashima Y, Fritton JC, Yakar S, Epstein S, Schaffler MB, Jepsen KJ, et al. Type 2 diabetic mice demonstrate slender long bones with increased fragility secondary to increased osteoclastogenesis. Bone. 2009;44(4):648-55.